Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis

23 Feb 2022

Abstract excerpt

Frontotemporal dementia refers to a group of neurodegenerative disorders characterized by behaviour and language alterations and focal brain atrophy. Amyotrophic lateral sclerosis is a rapidly progressing neurodegenerative disease characterized by loss of motor neurons resulting in muscle wasting and paralysis. Frontotemporal dementia and amyotrophic lateral sclerosis are considered to exist on a disease spectrum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyotrophic Lateral Sclerosis Research
Share to Cholinesterase and Neurodegenerative Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35202463
DOI: 10.1093/brain/awac077

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosisPMID 35202463Read ↗

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of ProteomicsSemantic proximity Read ↗

Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis DiagnosisSemantic proximity Read ↗

Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulationSemantic proximity Read ↗

Blood-based protein biomarkers in definite frontotemporal dementia: a case-control studySemantic proximity Read ↗

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene TherapySemantic proximity Read ↗

Advances in understanding the molecular basis of frontotemporal dementia.Semantic proximity Read ↗

Fluid biomarkers in frontotemporal dementia: past, present and futureSemantic proximity Read ↗

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read ↗

New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia.Semantic proximity Read ↗

Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?Semantic proximity Read ↗

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an updateSemantic proximity Read ↗

Recent advances in understanding frontotemporal degenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.